Evidence map›Paper›PMID 42211510›Full record

ArticleFrontiers in oncology2026

Case Report: Clinicopathological features and outcomes of superficial cervicovaginal myofibroblastoma: analysis of two cases and a review of the literature.

Xiaoli Cai, Yanli Liu, Yunfeng Niu, Xiaodan Shen, Qian Zhang, Lei Liang, Shuang Liu

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiaoli CaiDepartment of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Yanli LiuDepartment of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Yunfeng NiuDepartment of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Xiaodan ShenDepartment of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Qian ZhangDepartment of Ultrasound, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Lei LiangDepartment of Gynecology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.
Shuang LiuDepartment of Pathology, Bethune International Peace Hospital, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Superficial cervicovaginal myofibroblastoma (SCVM) is a benign mesenchymal tumor that arises from the superficial stromal layer of the submucosal vagina and cervix in females. This tumor is clinically rare, occurs most frequently in women aged 20-60 years, and is often difficult to distinguish from other soft tissue tumors of the female genital tract due to overlapping clinical and pathological features. Case description: Two cases of SCVM located in the vagina of female patients were reported. One patient presented with vaginal bleeding, whereas the other lesion was identified during a routine physical examination in the absence of obvious clinical symptoms. Both patients underwent surgical resection of the tumor. The final diagnosis of SCVM was established through an integrated evaluation of histopathological morphology, immunohistochemical profiles, and molecular pathology findings. During follow-up periods ranging from 6 months to 1 year, no tumor recurrence or additional clinical symptoms were observed. Conclusion: A review of the English-language literature identified a total of 78 reported cases of SCVM, and their clinical manifestations, pathological features, and treatment outcomes were summarized. The findings indicate that SCVM occurs predominantly in women of reproductive age, demonstrates slow growth and benign biological behavior, exhibits hormone-related characteristics, and is associated with a favorable prognosis following surgical excision, with recurrence being extremely rare. Accurate diagnosis depends on the combined assessment of morphological features and immunohistochemical findings to reliably differentiate SCVM from other mesenchymal tumors of the cervix and vagina.

Indexed as

immunohistochemistrymolecular pathologypathological diagnosisprognosissuperficial cervicovaginal myofibroblastomavaginal tumor

Identifiers

PMID42211510
PMCPMC13212141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.